CytoKi Pharma Highlighted in Medwatch

Lundbeckfonden takes former Novo-boss’ biotech baby under its wing.

A new drug at Novo Nordisk’s lab sparked such big interest for Rasmus Jørgensen that he decided to leave the diabetes giant and build his own biotech firm from it. Now Lundbeckfonden will help him find the money.

Read article